Plasma concentrations of LPL and LCAT are in putative association with females and alcohol use which are independent negative risk factors for coronary atherosclerosis among Japanese

Clinica Chimica Acta

Volumn 329, Issue 1-2, 2003, Pages 69-76

  Goto, Akitomo ^a   Sasai, Kanna ^a   Suzuki, Shogo ^a   Fukutomi, Tatsuya ^a   Ito, Shigenori ^a   Matsushita, Toyoaki ^b   Okamoto, Mitsuhiro ^b   Suzuki, Takahiko ^c   Itoh, Makoto ^a   Okumura Noji, Kuniko ^a   Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Owari Perfectural Hospital Cardiovascular Center   (Japan)

^c National Toyohashi Higashi Hospital   (Japan)

Author keywords

Alcohol; CETP; Coronary heart disease; HDL; Japanese; LCAT; LPL; Sex

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DRINKING BEHAVIOR; ENZYME BLOOD LEVEL; FEMALE; GENDER; HUMAN; JAPAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0037365489     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00021-4     Document Type: Article

References (45)

1. Marmot M.G., Syme S.L., Kagan A., Kato H., Cohen J.B., Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am. J. Epidemiol. 102:1975;514.
2. Sexena U., Klein M.G., Goldberg I.J. Transport of lipoprotein lipase across endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2254.
3. Nilsson-Ehle P.A., Garfinkel A.S., Schotz M.C. Lipolytic enzymes and plasma lipoprotein metabolism. Annu. Rev. Biochem. 49:1980;667.
4. Foger B., Ritsch A., Doblinger A., Wessels H., Patsch J.R. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16:1996;1430.
5. Ko K.W.S., Ohnishi T., Yokoyama S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein: evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J. Biol. Chem. 269:1994;28206.
6. Mead J.R., Cryer A., Ramji D.P. Lipoprotein lipase, a key role in atherosclerosis. FEBS Lett. 462:1999;1.
7. Shimada M., Ishibashi S., Inaba T., Yagyu H., Harada K., Osuga J.I.et al. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7242.
8. Yagyu H., Ishibashi S., Chen Z., Osuga J., Okazaki M., Perrey S.et al. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J. Lipid Res. 40:1999;1677.
9. Fan J., Unoki H., Kojima N., Sun H., Shimoyamada H., Deng H.et al. Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 276:2001;40071.
10. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37:1996;693.
11. Benlian P., De Gennes J.L., Foubert L., Zhang H., Gagne S.E., Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335:1996;848.
12. Nordestgaard B.G., Abildgaard S., Wittrup H.H., Steffensen R., Jensen G., Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation. 96:1997;1737.
13. Sing K., Ballantyne C.M., Ferlic L., Brugada R., Cushman I., Dunn J.K.et al. Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis. 144:1999;435.
14. Dugi K.A., Feuerstein I.M., Hill S., Shih J., Santamarina-Fojo S., Brewer H.B. Jr.et al. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17:1997;354.
15. Czarnecka H., Yokoyama S. Regulation of lecithin-cholesterol acyltransferase reaction by acyl acceptors and demonstration of its "idling" reaction. J. Biol. Chem. 268:1993;19334.
16. Czarnecka H., Yokoyama S. Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange. J. Biol. Chem. 271:1996;2023.
17. Solajic-Bozicevic N., Stavljenic A., Sesto M. Lecithin:cholesterol acyltransferase activity in patients with acute myocardial infarction and coronary heart disease. Artery. 18:1991;326.
18. Rosset J., Wang J., Wolfe B.M., Dolphin P.J., Hegele R.A. Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity. Clin. Biochem. 34:2001;381.
19. Hoeg J.M., Santamarina-Fojo S., Berard A.M., Cornhill J.F., Herderick E.E., Feldman S.H.et al. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11448.
20. Brousseau M.E., Kauffman R.D., Herderick E.E., Demosky S.J. Jr., Evans W., Marcovina S.et al. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 20:2000;450.
21. Furbee J.W. Jr., Sawyer J.K., Parks J.S. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. J. Biol. Chem. 277:2002;3511.
22. Forte T.M., Subbanagounder G., Berliner J.A., Blanche P.J., Clermont A.O., Jia Z.et al. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J. Lipid Res. 43:2002;477.
23. Wallentin L., Vikrot O. Lecithin:cholesterol acyl transfer in plasma of normal persons in relation to lipid and lipoprotein concentration. Scand. J. Clin. Lab. Invest. 35:1975;669.
24. Williams P.T., Albers J.J., Krauss R.M., Wood P.D. Associations of lecithin:cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men. Atherosclerosis. 82:1990;53.
25. Kobayashi J., Hashimoto H., Fukamachi I., Tashiro J., Shirai K., Saito Y.et al. Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin. Chim. Acta. 216:1993;113.
26. Hitsumoto T., Ohsawa H., Uchi T., Noike H., Kanai M., Yoshinuma M.et al. Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis. Atherosclerosis. 153:2000;391.
27. Hitsumoto T., Yoshinaga K., Noike H., Kanai M., Shirai K. Clinical significance of preheparin serum lipoprotein lipase mass in coronary vasospasm. Jpn. Circ. J. 65:2001;539.
28. Kobori K., Saito K., Ito S., Kotani K., Manabe M., Kanno T. A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measures human lecithin-cholesterol acyltransferase. J. Lipid Res. 43:2002;325.
29. Goto A., Sasai K., Suzuki S., Fukutomi T., Ito S., Matsushita T.et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis. 159:2001;153.
30. Mabuchi H., Koizumi J., Shimizu M., Takeda R. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 79:1989;225.
31. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499.
32. Nakamura M., Taniguchi Y., Yamamoto M., Hino K., Manabe M. Homogeneous assay of serum LDL-cholesterol on an automatic analyzer [Abstract]. Clin. Chem. 43:1997;S260.
33. Usui S., Kakuuchi H., Okamoto M., Mizukami Y., Okazaki M. Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin. Chem. 48:2002;1946.
34. Sasai K., Okumura-Noji K., Hibino T., Ikeuchi R., Sakuma N., Fujinami T.et al. Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients. Clin. Chem. 44:1998;1466.
35. Goto A., Sasai K., Suzuki S., Fukutomi T., Ito S., Matsushita T.et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis. 159:2001;153.
36. Marmot M.G. Alcohol and coronary heart disease. Int. J. Epidemiol. 13:1984;160.
37. Lindeman R.D., Romero L.J., Allen A.S., Liang H.C., Baumgartner R.N., Koehler K.M.et al. Alcohol consumption is negatively associated with the prevalence of coronary heart disease in the New Mexico Elder Health Survey. J. Am. Geriatr. Soc. 47:1999;396.
38. Stampfer M.J., Hu F.B., Manson J.E., Rimm E.B., Willett W.C. Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med. 343:2000;16.
39. Marmot M.G. Commentary: reflections on alcohol and coronary heart disease. Int. J. Epidemiol. 30:2001;729.
40. Parker D.R., McPhillips J.B., Derby C.A., Gans K.M., Lasater T.M., Carleton R.A. High-density-lipoprotein cholesterol and types of alcoholic beverages consumed among men and women. Am. J. Public Health. 86:1996;1022.
41. Lagrost L., Athias A., Herbeth B., Guyard-Dangremont V., Artur Y., Paille F.et al. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J. Biol. Chem. 271:1996;19058.
42. Sillanaukee P., Koivula T., Jokela H., Pitkajarvi T., Seppa K. Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL(3) cholesterol. Atherosclerosis. 152:2000;503.
43. Lussier-Cacan S., Bolduc A., Xhingnesse M., Niyonsenga T., Sing C.F. Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype. Arterioscler. Thromb. Vasc. Biol. 22:2002;824.
44. Hannuksela M., Marcel Y.L., Kesaniemi Y.A., Savolainen M.J. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J. Lipid Res. 33:1992;737.
45. Nishiwaki M., Ishikawa T., Ito T., Shige H., Tomiyasu K., Nakajima K.et al. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis. 111:1994;99.